HIM workflow transition guide: Life after Clintegrity

Navigating the shift beyond a trusted platform

For many health information management (HIM) departments, Nuance Clintegrity has been more than just a coding and CDI platform. It has functioned as a trusted operational backbone, recognized for its accuracy, reliability and role in strengthening documentation integrity across healthcare organizations.

The impact of Clintegrity’s end extends far beyond a simple technology replacement. This marks a meaningful disruption to established workflows, team routines, the systems that support revenue cycle performance and the success of your organization.

As organizations begin planning for life beyond Clintegrity, the priority is no longer just “what replaces it,” but rather:

• How do we protect operational stability during the transition?
• How do we preserve productivity and revenue integrity?
• How do we support HIM teams through significant change?

This guide is designed to help HIM leaders structure their next steps with clarity and confidence.

The reality of HIM transformation

Many organizations are asking the same question after receiving the Clintegrity end-of-life announcement: Where do we even begin?

The answer starts with one principle: planning before reacting.

Transitions of this scale are not just system migrations. They are workflow redesign initiatives that impact coding, CDI, auditing, compliance and revenue cycle strategy. Without a structured roadmap, organizations risk operational disruption, productivity loss and inconsistent documentation integrity.

The goal is not to replicate the past system. It is to intentionally design the next generation HIM operating model.

Key industry trends shaping HIM workflows

Understanding where the industry is headed helps reduce uncertainty and guides smarter decision-making. Several irreversible trends are shaping the future of HIM operations:

1. Cloud-based systems are no longer optional

Healthcare infrastructure is rapidly moving away from on-premise environments. Cloud-first architecture is becoming the default standard due to:

• scalability requirements for growing data volumes;

• enhanced security frameworks and continuous updates; and

• reduced dependency on internal infrastructure maintenance.

On-premises software, HIM systems are increasingly becoming operational dead ends, limiting innovation and integration capabilities.

2. Generative AI will live inside the workflow

Artificial intelligence is no longer an external enhancement layer. It is being embedded directly into coding and CDI workflows (not beside it).

Expect capabilities such as:

• automated encounter summarization;

• code suggestions with clinical rationale; and

• real-time physician prompts (system-dependent).

This shift moves AI from passive analytics to active clinical workflow participation.

3. Clinical Documentation Integrity (CDI) is moving earlier in the care cycle

CDI is no longer a post-discharge function. Instead, it is shifting upstream into the point of care.

This evolution includes:

• real-time CDI “nudging” during encounters;

• reduced reliance on retrospective physician queries; and

• improved documentation accuracy before discharge occurs.

The result is higher-quality documentation with fewer downstream corrections.

4. Coding is becoming a financial intelligence function

The role of coding is expanding beyond classification into financial analytics and operational intelligence.

Future systems will increasingly:

• predict DRG shifts before finalization;

• model payer behavior and reimbursement patterns;

• identify revenue leakage in near real time.

Coding teams are transitioning from pure production roles to hybrid auditing and analytical functions.

5. Workflow complexity will require multi-vendor ecosystems

No single platform may fully replace all Clintegrity capabilities. As a result, many organizations will adopt a best-of-breed ecosystem approach.

This requires:

• strong interoperability standards;

• API-driven integrations; and

• clear governance across multiple vendors.

Planning integration is just as important as selecting the primary platform.

Recommended HIM transition roadmap

To reduce disruption and maintain operational continuity, HIM leaders should follow a structured, phased approach. The timeline below provides a practical framework for navigating the transition.

Phase 1: Stabilize and assess (now through July 2026)

This phase is about understanding your current state before making any decisions.

1. Map current revenue cycle workflows

Document the full information flow from registration through billing and collections:

• EHR integrations;

• billing system dependencies;

• data warehouse connections; and

• custom rules, edits and encoder logic.
  
  

2. Identify Clintegrity dependencies

Not all platform usage is obvious. Identify:

• embedded workflows tied to Clintegrity;

• reporting functions;

• CDI and coding automation features; and
• hidden operational dependencies.
  
  

3. Inventory existing and planned projects

Align transition planning with initiatives already in motion:

• system upgrades;

• EHR modernization efforts; and

• revenue cycle optimization projects.
  
  

4. Define the future-state vision (2-5 years)

Ask leadership to define what success looks like:

• Fully automated coding?

• Real-time CDI?

• AI-supported documentation?

• Cloud-native architecture?

This vision becomes the foundation for all vendor evaluations.

5. Assess organizational readiness

Evaluate your team across three dimensions:

• comfort maintaining current-state replication;

• readiness for workflow redesign; and

• change management capacity.
  
  

6. Clarify budget reality

Determine whether funding is:

• already allocated within existing capital plans;

• requires new investment approval; and

• shared across multiple initiatives.

Phase 2: Evaluate solutions (now through October 2026)

Once current-state clarity is established, begin structured vendor evaluation.

Evaluation criteria should include:

• AI maturity and roadmap;

• encoder + CDI integration depth;

• audit and compliance capabilities;

• interoperability (FHIR, APIs);

• implementation timeline;

• total cost of ownership (upfront + recurring); and

• requests (customer references, vendor presence, training and support infrastructure).
  
  

Narrow to a shortlist

Reduce options to three primary vendors to allow for deeper analysis and workflow testing.

Phase 3: Workflow validation (through January 2027)

This is where decisions are pressure-tested against reality.

Key activities include:

• mapping workflow impact for each vendor;

• simulating real coding and CDI scenarios;

• validating encoder accuracy and automation logic; and

• testing integration with EHR and downstream systems.

The goal is to move beyond feature comparison and into operational fit.

Phase 4: Final selection and contracting (by March 2027)

At this stage, organizations finalize:

• vendor selection;

• contract terms and pricing models;

• implementation scope; and

• service level expectations.

Strong negotiation focus areas include:

• implementation support;

• data migration responsibilities;

• training and onboarding structure; and

• post-go-live optimization support.

Phase 5: Pilot and refine (by April 2027)

Before full rollout, implement controlled pilots.

Key considerations:

• facility-by-facility rollout strategy;

• big bang vs. phased implementation approach; and

• parallel workflows with legacy systems.

Refine operational areas such as:

• coding queues and productivity models;

• CDI workflows and escalation paths; and

• QA and audit processes.

Phase 6: Scale and optimize (by October 2027)

This phase focuses on enterprise-wide stabilization and performance tuning.

Deliverables include:

• full system deployment across facilities;

• workflow standardization;

• performance benchmarking; and

• continuous AI and rule optimization.

Post-go-live optimization becomes an ongoing operational function, not a one-time project.

Solution option matrix

DataGen does not have a relationship with the solutions listed by company, which are provided for your reference.

1. Microsoft health

Solution name

 Microsoft Cloud for Healthcare, coding and compliance solutions

Product overview

Pros and cons

2. Solventum

Solution name

Solventum™ 360 Encompass™ coding and audit software. There are a few different options available as well as standalone code finders. 

Product overview

Pros and cons

3. Optum

Solution name

EncoderPro, CAC and CDI (Optum360)  

Product overview

Pros and cons

4. Dolbey

Solution name

Fusion CAC and Fusion CDI

Product overview

Pros and cons

5. AGS Health

Solution name

AGS AI Platform with AI-enabled coding and CDI services

Product overview

Pros and cons

6. Oracle

Solution name

Oracle Health CDI and Oracle Health Clinical AI Agent 

Product overview

Pros and cons

7. Open Evidence

Solution name

Clinical AI reasoning platform  

Product overview

Pros and cons

8. Waystar

Solution name

Aware CDI Platform

Product overview

Pros and cons

8. Wolters Kluwer

Solutions overview

Health Language (coding and terminology tools)  

Product overview

Pros and cons

Final thoughts: Designing the next HIM operating model

The transition away from Clintegrity is not simply a replacement exercise. It is an opportunity to redefine how HIM departments operate in a more intelligent, automated and connected environment.

Organizations that succeed in this transition will not be the ones that replicate old workflows in new systems. They will be the ones that:

• reimagine coding and CDI as integrated financial intelligence functions;
• embrace cloud-native, interoperable ecosystems;
• invest in workforce transformation alongside technology change; and
• align operational design with future state healthcare delivery models.

With the right roadmap, HIM leaders can move from disruption to modernization, turning a mandated transition into a long-term strategic advantage. If you’re starting to plan your transition, we’re here to help. Contact us to get assistance.